Skip to main content

Advertisement

SpringerLink
Log in

Outcome of Patients with Known Metastatic Gastric Cancer Undergoing Resection with Therapeutic Intent

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Metastatic gastric cancer has a dismal prognosis. We identified a subset of patients where surgical resection with therapeutic intent was undertaken in the setting of known metastatic disease.

Methods

Review of a prospectively maintained database of gastric cancer patients at a single institution over a 19-year period was performed.

Results

Thirty-seven patients with metastatic disease known prior to resection with therapeutic intent were identified out of 3384 patients with gastric cancer (1%). Twelve patients had positive peritoneal cytology as the only evidence of metastasis, 21 had gross metastasis limited to peritoneal surfaces, one had peritoneal and ovarian metastasis, one had liver metastasis, one had retropancreatic lymph node metastasis, and one had a malignant pleural effusion. Thirty-six patients (97%) received chemotherapy prior to resection, and 30 (81%) received postoperative chemotherapy. The median time from diagnosis to resection was 4.5 months (range 1–22) in patients receiving preoperative chemotherapy. Median survival was 12 months after resection with no three-year survivors. Predictors of worse prognosis were cytologic or pathologic evidence of persistent metastatic disease at the time of resection or at laparoscopy within six weeks of resection (P < .01), N3 disease (P = .03), and total gastrectomy or additional organ resection (P = .04). Metastatic disease as evidenced by cytology only was not associated with improved prognosis.

Conclusions

Highly selected patients with metastatic gastric cancer undergoing surgical resection with therapeutic intent have a relatively poor prognosis. Persistent detectable metastatic disease after preoperative chemotherapy portends a particularly poor prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.
FIG. 3.
FIG. 4.
FIG. 5.

Similar content being viewed by others

References

  1. Ries LAG, Eisner MP, Kosary CL, eds. et al. (2005). SEER Cancer Statistics Review, 1975–2002. Bethesda, MD: National Cancer Institute.

    Google Scholar 

  2. Burke EC, Karpeh MS, Conlon KC, Brennan MF. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg 1997; 225(3):262–7

    Article  PubMed  CAS  Google Scholar 

  3. Bentrem DJ, Wilton A, Mazumdar M, et al. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol 2005; 12(5):347–53

    Article  PubMed  Google Scholar 

  4. Hundahl SA, Menck HR, Mansour EG, Winchester DP. The National Cancer Data Base report on gastric carcinoma. Cancer 1997; 80(12):2333–41

    Article  PubMed  CAS  Google Scholar 

  5. Sarela AI, Miner TJ, Karpeh MS, et al. Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg 2005; 243(2):189–195

    Article  Google Scholar 

  6. Hartgrink HH, Putter H, Klein Kranenbarg E, et al. Value of palliative resection in gastric cancer. Br J Surg 2002; 89(11):1438–43

    Article  PubMed  CAS  Google Scholar 

  7. Stomach. (2002) In: AJCC Cancer Staging Manual, Sixth Edition. New York: Springer Science and Business Media, Inc., pp 99–106

  8. Burke EC, Karpeh MS Jr, Conlon KC, Brennan MF. Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome. Ann Surg Oncol 1998; 5(5):411–5

    Article  PubMed  CAS  Google Scholar 

  9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457–62

    Article  Google Scholar 

  10. Sugarbaker PH, Yonemura Y. Palliation with a glimmer of hope: management of resectable gastric cancer with peritoneal carcinomatosis. Hepatogastroenterology 2001; 48(41):1238–47

    PubMed  CAS  Google Scholar 

  11. Haugstvedt T, Viste A, Eide GE, Soreide O. The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. Norwegian Stomach Cancer Trial. World J Surg 1989; 13(5):617–21

    Article  PubMed  CAS  Google Scholar 

  12. Maekawa S, Saku M, Maehara Y, et al. Surgical treatment for advanced gastric cancer. Hepatogastroenterology 1996; 43(7):178–86

    PubMed  CAS  Google Scholar 

  13. Kikuchi S, Arai Y, Morise M, et al. Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience. Hepatogastroenterology 1998; 45(22):1183–8

    PubMed  CAS  Google Scholar 

  14. Kikuchi S, Tsukamoto H, Mieno H, et al. Results of resection of gastric cancer with distant metastases. Hepatogastroenterology 1998; 45(20):592–6

    PubMed  CAS  Google Scholar 

  15. Inada T, Ogata Y, Kubota T, et al. D2-lymphadenectomy improves the survival of patients with peritoneal cytology-positive gastric cancer. Anticancer Res 2002; 22(1A):291–4

    PubMed  Google Scholar 

  16. Kunisaki C, Shimada H, Akiyama H, et al. Survival benefit of palliative gastrectomy in advanced incurable gastric cancer. Anticancer Res 2003; 23(2C):1853–8

    PubMed  Google Scholar 

  17. Yoshikawa T, Kanari M, Tsuburaya A, et al. Should gastric cancer with peritoneal metastasis be treated surgically? Hepatogastroenterology 2003; 50(53):1712–5

    PubMed  Google Scholar 

  18. Moriwaki Y, Kunisaki C, Kobayashi S, et al. Does the surgical stress associated with palliative resection for patients with incurable gastric cancer with distant metastasis shorten their survival? Hepatogastroenterology 2004; 51(57):872–5

    PubMed  Google Scholar 

  19. van der Burg ME, van Lent M, Buyse M, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 1995; 332(10):629–34

    Article  PubMed  Google Scholar 

  20. Fujimoto S, Takahashi M, Mutou T, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997; 79(5):884–91

    Article  PubMed  CAS  Google Scholar 

  21. Glehen O, Schreiber V, Cotte E, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004; 139(1):20–6

    Article  PubMed  CAS  Google Scholar 

  22. Hall JJ, Loggie BW, Shen P, et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 2004; 8(4):454–63

    Article  PubMed  Google Scholar 

  23. Yonemura Y, Kawamura T, Bandou E, et al. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005; 92(3):370–5

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Memorial Sloan–Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA

    Jason S. Gold MD, David P. Jaques MD, David J. Bentrem MD, Murray F. Brennan MD & Daniel G. Coit MD

  2. Department of Medicine, Memorial Sloan–Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA

    Manish A. Shah MD

  3. Department of Pathology, Memorial Sloan–Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA

    Laura H. Tang MD

Authors
  1. Jason S. Gold MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David P. Jaques MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David J. Bentrem MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Manish A. Shah MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Laura H. Tang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Murray F. Brennan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Daniel G. Coit MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel G. Coit MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gold, J.S., Jaques, D.P., Bentrem, D.J. et al. Outcome of Patients with Known Metastatic Gastric Cancer Undergoing Resection with Therapeutic Intent. Ann Surg Oncol 14, 365–372 (2007). https://doi.org/10.1245/s10434-006-9059-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9059-z

Keywords

Search

Navigation